Member Info for Laura2022

So this person was CEO for 12yrs and did what exactly?

Not very much by the looks

New CEO has done more in 3mths than Suzy and Satu clearly

Do you hold Uncanny ?

So in March 2024 I got this immediate reply from my car finance company that I'd been using for the last 5 cars

Thank you for your correspondence. We acknowledge your request for confirmation of whether your finance agreement(s) held with us had a discretionary commission arrangement between us and the broker / car dealer or any other entity involved in the transaction.

We note your request for a response within 28 days, however we are currently reviewing the arrangement relevant to your agreement(s) to respond to your request. We are therefore not treating this as a Data Subject Access Request (DSAR) under the GDPR. For clarity, the commission arrangement would not be disclosable within a DSAR as it is not Personal Data.

Due to high volumes of correspondence, we may not be able to respond within 28 days, however we will respond as soon as possible.

If you have held other agreements with us, we will reply separately on these.

For further information, you can visit the announcement on the FCA’s website https://www.fca.org.uk/carfinance

The Martin Lewis claims show and advice started back in early 2024

On his website you had a simple form that's pre written

I got a reply in March and update in Sept , they have till March 2025 I think then payouts start

Thanks again OT

From June

 In parallel, the Company is seeking ways to make the blood sampling required by its software more convenient for patients. This can potentially be achieved by using the software in other settings where frequent blood sampling already occurs, but also through exploration of the use of new diagnostic devices that can obtain and analyse blood samples in community or home settings (such at that being developed by our partner company Beyond Blood Diagnostics).

As the Company continues to develop its personalised dosing software, it will actively consider the most appropriate way to ring fence resources for this part of its business. Options under consideration include creation of a dedicated business unit, creation of a wholly owned subsidiary or a joint venture with a party with complementary technology/ capabilities. As further progress is made towards one of these, further updates will be provided accordingly.

Dr Peter Sargent, CEO, commented: “I’m really pleased that we’ve able to progress this initiative and the team are excited to build upon the partnership with DoseMe to further develop our Personalised Oncology Dosing Software”.

Dosing tool

This was the original update from June 2024, and now that we're 4 months on from that, i wonder if we're close to the next step with one of the options being considered was a JV

https://doseme-rx.com/en-gb/news-media/article/physiomics-adds-functionality-to-doseme

SCE virtually insolvent

FCRM went bust

FAB same revenues as PYC but x 10 the losses

Filtered

Just stick to you /thiopia ramping SCE FAB and FCRM

Jaari

1 why have you just arrived after 9yrs absence

2 why are you comparing FAB to a $900mlm company

3 why are you Thiopia of ADVFN

Well done for anyone who ,like myself and others bought EML under 0.3p

If you look at my other posts I believe others could follow suit

Found it

Is this person connected to mining sector?

https://www.lse.co.uk/rns/VAST/holdings-in-company-84lln5wspq9c840.html

Forgive me for asking

Who is this holder please

Many thanks

Looks to me that this could be linked to the 54mln buy reported mid week

Yes...some very strange goings on

Are they cancelled trades or off market ones ?

That wasn't the full answer Mouse

What shares ARE you invested in .?

Two years on from opening Oxfordshire’s largest co-working and flexible office space, Milton Park has announced a trio of life science biotechs, Physiomics, Outrun Therapeutics and Oxehealth, as the latest occupiers to move into Bee House.

Early findings are promising – analysis of trial data confirms the ability of the tool to predict levels and timing of episodes of hashtag#neutropenia associated with use of docetaxel and which can lead to serious side effects for patients

Thanks Ralph

This could be worth ££mlns to PYC

Early findings are promising – analysis of trial data confirms the ability of the tool to predict levels and timing of episodes of hashtag#neutropenia associated with use of docetaxel and which can lead to serious side effects for patients

It's 100% a buy

Was 0.915 to sell